FY2025 Earnings Forecast for R1 RCM Inc. Issued By Leerink Partnrs (NASDAQ:RCM)

R1 RCM Inc. (NASDAQ:RCM) – Stock analysts at Leerink Partnrs dropped their FY2025 earnings per share estimates for shares of R1 RCM in a research note issued on Thursday, June 27th. Leerink Partnrs analyst M. Cherny now forecasts that the healthcare provider will post earnings of $0.23 per share for the year, down from their previous estimate of $0.24. The consensus estimate for R1 RCM’s current full-year earnings is ($0.17) per share. Leerink Partnrs also issued estimates for R1 RCM’s FY2028 earnings at $0.88 EPS.

R1 RCM (NASDAQ:RCM) last posted its quarterly earnings results on Wednesday, May 8th. The healthcare provider reported ($0.08) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.03). R1 RCM had a negative return on equity of 1.16% and a negative net margin of 1.39%. The firm had revenue of $603.90 million for the quarter, compared to analyst estimates of $612.88 million. The firm’s quarterly revenue was up 10.7% on a year-over-year basis.

Other analysts also recently issued reports about the company. Truist Financial reissued a “hold” rating and issued a $16.00 price objective on shares of R1 RCM in a research note on Monday, April 1st. KeyCorp reaffirmed a “sector weight” rating on shares of R1 RCM in a research report on Wednesday, April 10th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $20.00 price target on shares of R1 RCM in a research report on Wednesday, April 10th. Citigroup raised R1 RCM from a “neutral” rating to a “buy” rating and set a $16.00 price target for the company in a research report on Wednesday, March 20th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $19.00 price target on shares of R1 RCM in a research report on Friday. Five equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat.com, R1 RCM presently has a consensus rating of “Moderate Buy” and an average target price of $15.83.

R1 RCM Stock Up 0.5 %

RCM stock opened at $12.56 on Monday. The company has a market cap of $5.29 billion, a P/E ratio of -157.00 and a beta of 0.86. R1 RCM has a fifty-two week low of $8.87 and a fifty-two week high of $18.70. The stock’s 50 day simple moving average is $12.43 and its 200 day simple moving average is $11.88. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.79 and a current ratio of 1.79.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. Mariner LLC grew its stake in shares of R1 RCM by 10.6% in the third quarter. Mariner LLC now owns 29,508 shares of the healthcare provider’s stock worth $445,000 after purchasing an additional 2,836 shares during the last quarter. Northern Trust Corp grew its stake in shares of R1 RCM by 17.8% in the third quarter. Northern Trust Corp now owns 1,515,507 shares of the healthcare provider’s stock worth $22,839,000 after purchasing an additional 229,395 shares during the last quarter. Tower Research Capital LLC TRC grew its stake in shares of R1 RCM by 419.2% in the third quarter. Tower Research Capital LLC TRC now owns 39,309 shares of the healthcare provider’s stock worth $592,000 after purchasing an additional 31,738 shares during the last quarter. Teza Capital Management LLC bought a new stake in shares of R1 RCM in the third quarter worth about $449,000. Finally, Schonfeld Strategic Advisors LLC grew its stake in shares of R1 RCM by 31.7% in the third quarter. Schonfeld Strategic Advisors LLC now owns 47,600 shares of the healthcare provider’s stock worth $717,000 after purchasing an additional 11,465 shares during the last quarter. Hedge funds and other institutional investors own 61.10% of the company’s stock.

R1 RCM Company Profile

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.